| 产品标题 |
产品货号 |
产品规格 |
厂家 |
| Spermatogenesis associated 9 (SPATA9) from ORIGENE TECHNOLOGIES | LY410397 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 6 (SPATA6) from ORIGENE TECHNOLOGIES | LY412785 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 13 (SPATA13), transcript variant 2 from ORIGENE TECHNOLOGIES | LY407201 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 2 (SPATA2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY416911 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 2 (SPATA2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY427705 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 22 (SPATA22), transcript variant 2 from ORIGENE TECHNOLOGIES | LY410013 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 22 (SPATA22), transcript variant 3 from ORIGENE TECHNOLOGIES | LY432942 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 22 (SPATA22), transcript variant 6 from ORIGENE TECHNOLOGIES | LY432882 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 7 (SPATA7), transcript variant 1 from ORIGENE TECHNOLOGIES | LY413064 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenesis associated 7 (SPATA7), transcript variant 2 from ORIGENE TECHNOLOGIES | LY421749 | 100 ug | ORIGENE TECHNOLOGIES |
| Spermatogenic leucine zipper 1 (SPZ1) from ORIGENE TECHNOLOGIES | LY410025 | 100 ug | ORIGENE TECHNOLOGIES |
| Sperm autoantigenic protein 17 (SPA17) from ORIGENE TECHNOLOGIES | LY413783 | 100 ug | ORIGENE TECHNOLOGIES |
| Sperm equatorial segment protein 1 (SPESP1) from ORIGENE TECHNOLOGIES | LY407913 | 100 ug | ORIGENE TECHNOLOGIES |
| Sperm flagellar 1 (SPEF1) from ORIGENE TECHNOLOGIES | LY414579 | 100 ug | ORIGENE TECHNOLOGIES |
| Sperm flagellar 2 (SPEF2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY411032 | 100 ug | ORIGENE TECHNOLOGIES |
| Sperm flagellar 2 (SPEF2), transcript variant 2 from ORIGENE TECHNOLOGIES | LY408150 | 100 ug | ORIGENE TECHNOLOGIES |
| SPEG - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN426497 | 1 kit | ORIGENE TECHNOLOGIES |
| Speg - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516591 | 1 kit | ORIGENE TECHNOLOGIES |
| SPEM1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN407819 | 1 kit | ORIGENE TECHNOLOGIES |
| Spem1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN516592 | 1 kit | ORIGENE TECHNOLOGIES |
| SPEN - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN413922 | 1 kit | ORIGENE TECHNOLOGIES |
| Transthyretin (TTR) from ORIGENE TECHNOLOGIES | LY400134 | 100 ug | ORIGENE TECHNOLOGIES |
| ALS2CR11 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN406143 | 1 kit | ORIGENE TECHNOLOGIES |
| ALS2CR12 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN417922 | 1 kit | ORIGENE TECHNOLOGIES |
| Als2cr12 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501172 | 1 kit | ORIGENE TECHNOLOGIES |
| Als2cr11 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501171 | 1 kit | ORIGENE TECHNOLOGIES |
| ALS2 C-terminal like (ALS2CL), transcript variant 3 from ORIGENE TECHNOLOGIES | LY405354 | 100 ug | ORIGENE TECHNOLOGIES |
| ALS2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415448 | 1 kit | ORIGENE TECHNOLOGIES |
| Als2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501169 | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH2B - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN416660 | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN202135 | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN202135BN | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN202135LP | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH1 - human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN202135RB | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH1 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN402135 | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH2 - KN2.0, Human gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN415027 | 1 kit | ORIGENE TECHNOLOGIES |
| Asah1 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501642 | 1 kit | ORIGENE TECHNOLOGIES |
| Asah2 - KN2.0, Mouse gene knockout kit via CRISPR from ORIGENE TECHNOLOGIES | KN501643 | 1 kit | ORIGENE TECHNOLOGIES |
| ASAH1 Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH312434 | 10 ug | ORIGENE TECHNOLOGIES |
| ASAM Mass Spectrometry Standard from ORIGENE TECHNOLOGIES | PH303362 | 10 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 3 (MAGEA3) from ORIGENE TECHNOLOGIES | LY417358 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 5 (MAGEA5) from ORIGENE TECHNOLOGIES | LY412121 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 9 (MAGEA9) from ORIGENE TECHNOLOGIES | LY417353 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 10 (MAGEA10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY423269 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 10 (MAGEA10), transcript variant 1 from ORIGENE TECHNOLOGIES | LY425298 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 10 (MAGEA10), transcript variant 2 from ORIGENE TECHNOLOGIES | LY412120 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 11 (MAGEA11), transcript variant 1 from ORIGENE TECHNOLOGIES | LY401651 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 11 (MAGEA11), transcript variant 2 from ORIGENE TECHNOLOGIES | LY423270 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 12 (MAGEA12), transcript variant 2 from ORIGENE TECHNOLOGIES | LY432867 | 100 ug | ORIGENE TECHNOLOGIES |
| Melanoma antigen family A, 2 (MAGEA2), transcript variant 1 from ORIGENE TECHNOLOGIES | LY417357 | 100 ug | ORIGENE TECHNOLOGIES |